SROA President Brenda Marie Palo welcomed participants to the society’s 37^th annual and first Virtual Annual Meeting on Monday, October 26. She introduced John Cashion, this year’s keynote speaker.

In this Q&A, James Hugh, MHA senior vice president of American Medical Accounting and Consulting, Inc., (AMAC) shared his thoughts on the 2020 CMS Final Rules.

October 2020 marks the 35^th anniversary of National Breast Cancer Awareness Month. Every October for the past 35 years, charities in October raise money to support breast cancer research and to support patients and survivors. The pink ribbon has become an internationally recognized symbol.

 On October 26–30, SROA will host its 37^th Annual Meeting and its 1^st virtual meeting. Like prior annual meetings, there will be a keynote presentation, general presentations and workshops.

Tina Berry is SROA’s new emerging professional-at-large. She participated in a Q&A to talk about her new role.

Alex Wirth joins SROA Soundboard, SROA's podcast for radiation oncology administrators to discuss cybersecurity risks that exist with the increased use of telehealth during the pandemic.

Mike Grindstaff, director, Radiation Oncology at TriHealth Cancer Institute in Cincinnati, Ohio, is SROA’s new member-at-large. He participated in a Q&A to talk about his new role.

SROA’s New President-Elect

Aaron Brammer, administrator at Winship Cancer Institute of Emory University in Atlanta, GA, is SROA’s new president-elect. He participated in a Q&A to talk about his new role.

“I find that showing people how to behave is better than telling them how”–– John Paul DeJoria

Lee Silber joined SROA to discuss generations during his “Generation We” webinar. Silber, an award-winning author of 26 books, including two best sellers, spoke about the multigenerational workforce, what makes each generation special and commonalities with each generation.

When she was diagnosed with ovarian cancer, Kimberly Richardson didn’t have a positive experience. During recovery for what doctors thought was an ovarian cyst, she was tapped on her shoulder and told, “Kim, it’s cancer. We’ll talk with you about it when you’re fully awake.” Later, her oncologist scribbled her specific tumor type––Ovarian Granulosa Cell Tumor Stage 3A, a rare form of cancer—on the back of her referral. “I remember very clearly that my oncologist scribbled on the back of my referral for a follow-up test. It said ‘3A GCT.’ That was the very first time I was introduced to my stage and the type of cancer I had, and I had just met my oncologist,” she said.